MedTrace Logo

Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.

NCT02510079 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2021-11-16

No results posted yet for this study

Summary

The primary purpose of this research study is to determine the safety of injecting ones own Schwann cells to augment sural nerve autografts after a severe, non-lacerating injury to the sciatic nerve has occurred.

Conditions

  • Sciatic Nerve Injury

Interventions

BIOLOGICAL

Autologous human Schwann cells

Schwann cells harvested from the sural nerve will be autologously transplanted along sural nerve autografts wrapped in a collagen matrix (Duragen).

Sponsors & Collaborators

  • The Miami Project to Cure Paralysis

    collaborator OTHER

  • W. Dalton Dietrich

    lead OTHER

Principal Investigators

  • W. Dalton Dietrich, MD · University of Miami

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02510079 on ClinicalTrials.gov